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BACKGROUND: Studies from around the world have shown that suicide risk is increased in cancer patients, but no previous detailed
analysis has been carried out in England.
METHODS: We calculated standardised mortality ratios (SMRs) for suicide in 206129 men and 211443 women diagnosed with cancer
in South East England between 1996 and 2005, relative to suicide rates in the general population.
RESULTS: We found a significantly increased risk of suicide in men (SMR 1.45, 95% confidence interval (CI) 1.20–1.73) and a
moderately increased risk in women (SMR 1.19, 95% CI 0.88–1.57). In both sexes, relative risk of suicide was greatest in the first year
after cancer diagnosis (SMR for men 2.42, 95% CI 1.84–3.13; SMR for women 1.44, 95% CI 0.82–2.33), and was also greater in
individuals diagnosed with types of cancer with high fatality (SMR for men 2.67, 95% CI 1.71–3.97; SMR for women 2.17, 95% CI
0.80–4.73).
CONCLUSION: There is a critical period immediately after the diagnosis of cancer during which the excess risk of suicide is particularly
high. Carers need to be aware of the importance of attending to both the physical and emotional needs of cancer patients and cancer
survivors.
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Patients diagnosed with life-threatening conditions such as cancer
experience painful emotional reactions, which can lead to suicidal
thoughts. The risk of suicide in cancer patients has been reported
as elevated relative to that of the general population in several
countries: Italy (Crocetti et al, 1998; Miccinesi et al, 2004),
Switzerland (Chatton-Reith et al, 1990; Levi et al, 1991), Denmark
(Storm et al, 1992; Yousaf et al, 2005; Christensen et al, 2006;
Schairer et al, 2006), Norway (Hem et al, 2004; Schairer et al,
2006), Sweden (Allebeck et al, 1989; Allebeck and Bolund, 1991;
Bjo ¨rkenstam et al, 2005; Schairer et al, 2006; Bjo ¨rkholm et al,
2007), Finland (Louhivuori and Hakama, 1979; Schairer et al,
2006), Estonia (Innos et al, 2003), Australia (Dormer et al, 2008),
Japan (Tanaka et al, 1999), Scotland (Camidge et al, 2007) and the
United States of America (Fox et al, 1982; Llorente et al, 2005;
Kendal, 2007; Miller et al, 2008; Misono et al, 2008). The majority
of studies report a higher relative risk in men than in women. The
risk has been shown to be greatest in the first months after
diagnosis (Crocetti et al, 1998; Tanaka et al, 1999; Innos et al, 2003;
Hem et al, 2004; Llorente et al, 2005; Yousaf et al, 2005; Dormer
et al, 2008), and to increase with the severity of the disease
(Louhivuori and Hakama, 1979; Storm et al, 1992; Tanaka et al,
1999; Miccinesi et al, 2004; Bjo ¨rkenstam et al, 2005; Yousaf et al,
2005; Kendal, 2007; Dormer et al, 2008).
A series of recent initiatives in cancer care in England have
sought to improve the provision and quality of supportive and
palliative care services (National Institute for Clinical Excellence,
2004), and to improve the quality of life of cancer survivors
(Department of Health, 2007). In the year following the diagnosis
of cancer, around 1 in 10 patients are reported to experience
symptoms of either depression or anxiety severe enough to require
intervention by specialist psychological or psychiatric services
(National Institute for Clinical Excellence, 2004). To our knowl-
edge no previous detailed analysis of suicide risk in individuals
with cancer has been carried out in England, although a recent
study, covering the period 1981 to 1995, has reported on hospital
admissions and deaths relating to deliberate self-harm in cancer
patients in Scotland (Camidge et al, 2007). In this study, we aim to
provide new information relating to suicide risk in patients
diagnosed with cancer in South East England during the more
recent time period of 1996 to 2005.
METHODS
The records of all patients diagnosed with an invasive cancer
between 1996 and 2005 were extracted from the database of the
Thames Cancer Registry. This is a population-based registry,
covering around 12 million people residing in an area of South
East England comprising London, Kent, Surrey and Sussex. We
excluded patients registered only from a death certificate or for
whom the recorded date of diagnosis was the same as the date of
death (9.5% of all cases), and those with a date of death but no
recorded cause of death (0.54% of all deaths). We also excluded
patients aged less than 15 years at cancer diagnosis, as suicide
rates in the general population are not available for this age group.
Cases of suicide were identified either from the ICD cause of death
code (where present) or from appropriate text fields in the
death certificate. The relevant ICD-9 codes were E950-E959 and
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yE980-E989 (excluding E988.8), with corresponding ICD-10 codes
X60-X84 and Y10-Y34 (but excluding Y33.9 where a coroner’s
verdict was pending). These were chosen to be consistent with
those used by National Statistics (Brock et al, 2006). Keywords
searched for in the text fields were ‘suicide’, ‘killed him/herself’,
‘own life’ and ‘overdose’. Of the 166 suicides identified, 8 (4.8%)
were found by text analysis alone.
Standardised mortality ratios (SMRs) were calculated by
dividing the observed numbers of suicides by the numbers
expected, derived from age/sex/calendar period-specific suicide
rates for the London and South East Coast Strategic Health
Authorities provided by the Office for National Statistics. Time at
risk was calculated from cancer diagnosis to death or end of the
study period (31 December 2005). For individuals with more than
one cancer diagnosis, the date of the first cancer was taken as the
start of the at-risk period. SMRs were calculated separately for men
and women, and were examined in relation to a number of factors:
time since cancer diagnosis, age at diagnosis, stage of disease
(1¼localised; 2¼extension beyond the organ of origin; 3¼local
lymph node involvement; 4¼metastases), fatality of the cancer
type (based on relative survival figures, with those cancer types
with a 5-year survival of less than 10% being classified as having
‘high’ fatality), calendar period of diagnosis and deprivation
(measured in quintiles using the income domain of the Indices of
Multiple Deprivation (IMD) 2004, assigned on the basis of place of
residence at the time of diagnosis (Neighbourhood Renewal Unit,
2004)). A Cox proportional hazards regression model was fitted
using all of these factors as covariates, in an attempt to estimate
their independent and joint effects on the risk of committing
suicide after being diagnosed with cancer.
RESULTS
A total of 206129 male and 211443 female cancer patients with a
combined follow-up of 1.1 million person-years were included in
the analysis. Among these, we observed 166 suicides (117 in men
and 49 in women). The mean age at diagnosis of first cancer in
those committing suicide was 67.9 years in men and 63.4 years in
women. Mean age at suicide was 69.9 years in men and 65.9 years
in women. Table 1 shows the SMRs and 95% confidence intervals
(CIs) for suicide by sex and time since diagnosis. Overall, there was
a significantly increased risk of suicide in men (SMR 1.45; 95% CI
1.20–1.73). In women, the SMR was lower and did not reach
statistical significance (SMR 1.19, 95% CI 0.88–1.57). In both sexes
there was a downward trend in relative risk of suicide with
increasing time since diagnosis: SMRs at o1, 1–5 and 45 years
after diagnosis were 2.42 (1.84–3.13), 1.04 (0.76–1.39) and 1.01
(0.54–1.73) for men and 1.44 (0.82–2.33), 1.10 (0.71–1.63) and
1.08 (0.47–2.14) for women.
Table 2 shows the mutually adjusted hazard ratios from the Cox
regression analysis. In both men and women, the risk of suicide was
highest in the first year after cancer diagnosis. Overall, there was a
suggestion of increasing risk of suicide with increasing age. The
more fatal types of cancer carried the highest risk of suicide
in both men and women, but a strong effect of advanced stage
of disease was evident only in women. There were no significant
trends in suicide risk over the period studied. There was a tendency
for those from more deprived areas (higher IMD 2004 quintiles) to
be at greater risk than those from more affluent areas: suicide risk
was highest in the socio-economically deprived groups of women.
DISCUSSION
We have found an excess of suicides in patients diagnosed with
cancer in South East England, which is most pronounced in the
first year following diagnosis and higher in men than in women.
These results are generally consistent with previous findings. In
the majority of studies that have compared suicide risks between
the sexes, men were found to have a higher relative risk than
women (Fox et al, 1982; Allebeck et al, 1989; Levi et al, 1991; Innos
et al, 2003; Hem et al, 2004; Miccinesi et al, 2004; Yousaf et al,
2005; Dormer et al, 2008; Misono et al, 2008).
In both men and women we found the relative risk of suicide to
be greatest in the first year after diagnosis. This is also consistent
with many of the previous studies, which found a maximum risk
within the first few months (Crocetti et al, 1998; Tanaka et al, 1999;
Innos et al, 2003; Hem et al, 2004; Llorente et al, 2005; Yousaf et al,
2005; Dormer et al, 2008) or the first 1–2 years (Allebeck et al,
1989; Chatton-Reith et al, 1990; Levi et al, 1991; Storm et al, 1992;
Miccinesi et al, 2004; Bjo ¨rkholm et al, 2007). Dormer et al (2008)
Table 1 Standardised mortality ratios for suicide in cancer patients, by
sex and time since diagnosis
Years since diagnosis
o11 – 545 Total
Suicides 58 46 13 117
Males
SMR 2.42 1.04 1.01 1.45
95% CI 1.84–3.13 0.76–1.39 0.54–1.73 1.20–1.73
Suicides 16 25 8 49
Females
SMR 1.44 1.10 1.08 1.19
95% CI 0.82–2.33 0.71–1.63 0.47–2.14 0.88–1.57
Suicides 74 71 21 166
All
SMR 2.11 1.06 1.04 1.36
95% CI 1.65–2.65 0.83–1.34 0.64–1.59 1.16–1.58
SMR¼standardised mortality ratio; CI¼confidence interval.
Table 2 Adjusted hazard ratios and 95% confidence intervals for suicide
in cancer patients in South East England 1996–2005
Factor Males Females All
Time since diagnosis (years)
0–1 2.09 (1.39–3.15) 1.14 (0.59–2.22) 1.78 (1.26–2.50)
41 1.00 1.00 1.00
Age at diagnosis (years)
15–60 1.00 1.00 1.00
61–75 0.78 (0.24–2.59) 2.88 (0.46–18.04) 1.29 (0.47–3.54)
475 1.24 (0.24–6.44) 1.37 (0.10–18.66) 1.57 (0.40–6.17)
Stage
1–2 1.00 1.00 1.00
3–4 0.79 (0.43–1.44) 2.41 (1.25–4.64) 1.16 (0.76–1.76)
N/K 1.38 (0.94–2.05) 1.10 (0.53–2.29) 1.31 (0.93–1.85)
Fatality of cancer
Low 1.00 1.00 1.00
High 1.76 (1.10–2.81) 1.57 (0.65–3.81) 1.87 (1.24–2.82)
Period of diagnosis
1996–1999 1.00 1.00 1.00
2000–2002 0.98 (0.64–1.49) 0.96 (0.50–1.83) 1.00 (0.70–1.42)
2003–2005 1.10 (0.66–1.85) 1.07 (0.44–2.57) 1.12 (0.72–1.75)
IMD 2004 quintile
1–2 1.00 1.00 1.00
3 1.07 (0.65–1.75) 1.76 (0.84–3.70) 1.24 (0.82–1.87)
4–5 1.06 (0.71–1.60) 1.45 (0.75–2.82) 1.17 (0.83–1.65)
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increased risk 12–14 months after diagnosis, which they suggested
might be a response to cancer recurrence or treatment failure. An
international study of women with breast cancer (Schairer et al,
2006) found an elevated risk throughout the follow-up period,
including more than 25 years after diagnosis.
Some investigators (Chatton-Reith et al, 1990; Miccinesi et al,
2004; Schairer et al, 2006) have found an increase in relative risk
with increasing age. Others (Fox et al, 1982; Allebeck et al, 1989;
Levi et al, 1991; Bjo ¨rkenstam et al, 2005; Yousaf et al, 2005; Dormer
et al, 2008) found no such relationship, whereas Innos et al (2003)
found the highest risk in men aged 15–49, with a tendency for the
risk to decline in older age groups. In our study, there was a
suggestion of increasing suicide risk with increasing age.
Suicide risk has been shown to be associated with stage of
disease, with higher risks in patients with non-localised disease
(Louhivuori and Hakama, 1979; Storm et al, 1992; Yousaf et al,
2005) or distant metastases (Tanaka et al, 1999; Kendal, 2007). In a
case–control study of Americans aged 65 or more (Miller et al,
2008), the only medical condition found to be associated with
suicide was cancer, and metastases were significantly more
common in cancer patients who committed suicide than in those
who did not. In our study, the risk of suicide was significantly
higher in women with later stage disease, but not in men. We
found a significantly raised SMR in men with unknown stage (1.78,
95% CI 1.31–2.37). However, this group of patients were on
average older and had shorter survival than the staged patients,
and the relationship became non-significant after adjusting for
these factors in the full model.
Suicide risk has also been shown to be higher in patients
diagnosed with cancers that have a poor prognosis (Storm et al,
1992; Yousaf et al, 2005; Dormer et al, 2008) or a low survival rate
(Miccinesi et al, 2004; Bjo ¨rkenstam et al, 2005). Misono et al (2008)
found the risk to be highest for lung, stomach or head and neck
cancers, whereas Innos et al (2003) found the greatest risks in men
with cancers of the oesophagus or pancreas. We found signifi-
cantly higher risks associated with cancers at sites with high
fatality rates (5-year relative survival of less than 10%) when
compared with those at other sites, with SMRs of 2.42 (1.84–3.13)
for men and 1.44 (0.82–2.33) for women.
There is some evidence from other studies (Hem et al, 2004;
Miccinesi et al, 2004; Bjo ¨rkenstam et al, 2005) that the relative risk
of suicide in cancer patients is decreasing in more recent years.
This may be due to new treatments, increased survival and a better
public awareness that cancer is not necessarily a fatal condition –
all of which should improve a patient’s reaction to a diagnosis
of cancer. However, Fox et al (1982) found no significant trend
with decade of diagnosis, and two Danish studies (Storm et al,
1992; Yousaf et al, 2005) found increasing risks over time. After
adjusting for confounding factors, we found no significant trend
over time in the population of South East England.
Chatton-Reith et al (1990) found suicide relative risk to be lower
in the upper socio-economic classes. There is a suggestion of this
in our data, with lower risks in the two most affluent quintiles,
although the differences did not reach statistical significance and
were attenuated after adjustment for other factors, including
disease stage.
The results of our and other studies indicate that there is a
critical period immediately after diagnosis during which the excess
risk of suicide in cancer patients is particularly high. Patients who
survive this initial period are much less likely to commit suicide,
although the risk can remain elevated for many years. The risk of
suicide is especially high in those diagnosed with cancers such as
lung, pancreas or oesophagus, where the prognosis is poor and the
symptoms painful or likely to interfere with vital functions such as
breathing and eating. The SMRs for these cancers in the first year
after diagnosis were 4.60 (2.51–7.72), 6.79 (1.40–19.83) and 6.52
(2.12–15.22) respectively.
Studies (Henriksson et al, 1995; Akechi et al, 2001, 2002a,b;
Filiberti et al, 2001; Smith et al, 2004; Walker et al, 2008) have
consistently shown that substantial pain, major depression, loss
of autonomy and independence, emotional distress and impaired
physical functioning are the clinical factors most commonly
associated with suicidal thoughts in cancer patients. One recent
survey of nearly 3000 cancer patients attending a regional cancer
centre in Scotland found that almost 8% reported having thoughts
of being better off dead or of hurting themselves in some way for
at least several days in the previous 2 weeks (Walker et al, 2008).
As pointed out, not all of these patients will attempt to harm
themselves, but acknowledgment of emotional distress should be
a core aspect of modern cancer care, together with careful control
of symptoms such as pain. As stressed by Maliski et al (2003),
awareness is important in attending to both the physical and
emotional needs of cancer patients and cancer survivors.
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